Capsular contracture is the most frequent complication in breast augmentation. It has multifactorial aetiology but biofilm is suggested to have a central role in the capsular contracture pathogenesis. To sterilize the breast cavity and the implant after insertion we decided to use a mixture of oxygen and ozone, using ozone sterilizing properties with no subsequent contamination related to manipulation.
Introduction
Capsular contracture (CC) is the most frequent complication in breast augmentation and in reconstruction with breast implants, increasing the number of reoperations. Various hypotheses have been formulated on the aetiology of CC. [1] [2] [3] The silicone oil oozing through the wall of implants and the prosthesis surface, from smooth to textured polyurethane coated, microtextured and smooth again, was studied. Currently, it is implied the multifactorial aetiology of CC though an important role attributed to biofilm formation and subclinical infections. 4, 5 Biofilm can cause subclinical infections over time that may play an important role in the genesis of CC. 6, 7 Many surgeons believe that it is important to prepare a sterile breast cavity that should remain sterile after introducing the breast implant. Using prosthesis with a smooth surface provide germs less nesting and Notouch techniques with Keller funnel have been developed, 8 to decrease the contact with the patient skin but are made partially ineffective by the manipulations of the surgeon in order to correctly position the implants inside the cavity. To guarantee greater sterility, some surgeons prefer peripheral access away from the nipple in order to avoid bacterial contamination of the lactiferous ducts during the manipulation of the mammary gland. 9, 10 To minimize the bacterial load we sterilised the cavity with a sterilizing mixture of oxygen-ozone due to the bactericidal, fungicidal and virustatic properties of the ozone. [11] [12] [13] [14] [15] The treatment aims to reduce the incidence of capsular contracture in patients undergoing cosmetic breast augmentation.
Materials and Methods
We used the Multiossigen Medical 99 IR Oxygen-Ozone therapy device with 25 mcg/cm 3 ozone concentration. The ozone does not interact with smooth or texturized silicone implants so it will not have negative consequences on the implants; to use the periareolar access we used the ozone to sterilize both the implant and the cavity after surgery. Nelaton catheter is left in the cavity after the prosthesis insertion; the gland is sutured with interrupted stitches and the skin with intradermal suture leaving the catheter in place. After completing the suture the catheter is insufflated with 100 cm 3 of oxygen-ozone mixture ( Figure 1 ) and let in act for 5 minutes. Draining off excess gas through the catheter, remove the catheter and close the intradermal suture (Figure 2 ), thus avoiding any further risk of bacterial contamination.
Results and Discussion
Oxygen-ozone therapy is successfully used for various purposes particularly for the treatment of infections due to its bactericidal, fungicidal and virustatic properties. We used it to interact with surfaces potentially contaminated by bacteria and that can generate CC through the formation of biofilm and consequent subclinical infections. Its harmlessness to human tissues and its important sterilizing action make it ideal for the sterilization of implanted prosthesis and implant cavity during surgery. 
Conclusions
The ozone therapy using autohemotherapy could also be used, but we believe that local treatment with direct contact between the ozone and the prosthesis surface may be more appropriate to remove any risk of biofilm formation. As CC may appear after many years, long term follow-up will thus be necessary to know the real efficacy of this method, but we believe that it is able to reduce the bacterial load of the implant pocket reducing the risk of capsular contraction. 
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